Infliximab Therapeutic Drug Monitoring in Inflammatory Bowel Disease Virtual Biologics Clinic Leads to Durable Clinical Results

Infliximab Therapeutic Drug Monitoring in Inflammatory Bowel Disease Virtual Biologics Clinic Leads to Durable Clinical Results

Background: Therapeutic drug monitoring (TDM) of infliximab (IFX) trough levels and anti-drug antibodies in conjunction with symptoms, disease history, and investigations can aid decision-making. This study evaluated 1-year outcomes of patients with decisions that were altered on the basis of TDM re...

Full description

Bibliographic Details
Main Authors: Rebecca Sagar, Marco V. Lenti, Tanya Clark, Helen J. Rafferty, David J. Gracie, Alexander C. Ford, Anthony O’Connor, Tariq Ahmad, P. John Hamlin, Christian P. Selinger
Format: Article
Language:English
Published: Karger Publishers 2021-04-01
Series:Inflammatory Intestinal Diseases
Online Access:https://www.karger.com/Article/FullText/515593

Internet

https://www.karger.com/Article/FullText/515593

Similar Items